APMD Apnimed Inc revenue, earnings and financials
For the quarter ended June 30, 2026, Apnimed Inc reported revenue of $12.1M (down 29.4% from a year earlier), net income of $126M and diluted EPS of n/a.
APMD quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue $12.1M (down 29.4% year over year), net income $126M, EPS n/a
- Quarter ended Mar 31, 2026: revenue n/a, net income $67.7M, EPS n/a
- Quarter ended Jun 30, 2025: revenue $17.1M, net income −$69.5M, EPS n/a
- Quarter ended Mar 31, 2025: revenue n/a, net income −$28.6M, EPS n/a
APMD balance sheet
- Jun 30, 2026: cash $173M, total assets $195M, total liabilities $126M, shareholders' equity −$176M, long-term debt $40.3M
- Dec 31, 2025: cash $41.9M, total assets $72.9M, total liabilities $225M, shareholders' equity −$373M, long-term debt $0